New hope for tough depression: boosting a Fast-Acting drug with talk therapy
NCT ID NCT06431386
Summary
This study tested whether combining a fast-acting antidepressant nasal spray (esketamine) with a specific type of talk therapy (Behavioral Activation) works better than the spray alone for people with hard-to-treat depression. The goal was to see if the therapy, done while the drug improves mood, could help make recovery last longer. The trial was small and has ended.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Royal Ottawa Mental Health Centre
Ottawa, Ontario, K1Z 7K4, Canada
Conditions
Explore the condition pages connected to this study.